Nordea Investment Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-35,167
Closed -$11.6M 948
2024
Q1
$11.6M Sell
35,167
-815
-2% -$200K 0.01% 400
2023
Q4
$6.79M Sell
35,982
-821
-2% -$155K 0.01% 473
2023
Q3
$7.47M Sell
36,803
-338
-0.9% -$79.9K 0.01% 423
2023
Q2
$10.8M Buy
37,141
+3,277
+10% +$910K 0.01% 386
2023
Q1
$7.35M Sell
33,864
-450
-1% -$87.7K 0.01% 440
2022
Q4
$6.99M Buy
+34,314
New +$8.68M 0.01% 445

Other funds holding SWAV

Nordea Investment Management's SWAV Position: Q2 2024 in Review

Nordea Investment Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 35,167 shares — an estimated $11.6M sold.

Nordea Investment Management first reported a position in SWAV in Q4 2022 and held it in 6 quarters. The position peaked at $11.6M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Nordea Investment Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Nordea Investment Management sold 35,167 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $11.6M.
  • Nordea Investment Management first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
  • Nordea Investment Management's Shockwave Medical, Inc. Common Stock position peaked at $11.6M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Nordea Investment Management's 13F filing for Q2 2024, filed 8 Aug 2024.